Works matching AU Mohammadi, Hamed


Results: 210
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility.

    Published in:
    International Journal of Rheumatic Diseases, 2021, v. 24, n. 4, p. 567, doi. 10.1111/1756-185X.14079
    By:
    • Ebrazeh, Mehrdad;
    • Ezzatifar, Fatemeh;
    • Torkamandi, Shahram;
    • Mohammadi, Fatemeh Sadat;
    • Salimifard, Sevda;
    • Gowhari Shabgah, Arezoo;
    • Hemmatzadeh, Maryam;
    • Aslani, Saeed;
    • Babaie, Farhad;
    • Jadidi‐Niaragh, Farhad;
    • Gholizadeh Navashenaq, Jamshid;
    • Mohammadi, Hamed
    Publication type:
    Article
    17

    Susceptibility to ERAP1 gene single nucleotide polymorphism modulates the inflammatory cytokine setting in ankylosing spondylitis.

    Published in:
    International Journal of Rheumatic Diseases, 2019, v. 22, n. 4, p. 715, doi. 10.1111/1756-185X.13494
    By:
    • Hemmatzadeh, Maryam;
    • Babaie, Farhad;
    • Ezzatifar, Fatemeh;
    • Mohammadi, Fatemeh S.;
    • Ebrazeh, Mehrdad;
    • Golabi Aghdam, Shirin;
    • Hajaliloo, Mehrzad;
    • Azizi, Gholamreza;
    • Gowhari Shabgah, Arezoo;
    • Shekari, Najibeh;
    • Sehati, Nasrin;
    • Hosseinzadeh, Ramin;
    • Mohammadi, Hamed;
    • Babaloo, Zohreh
    Publication type:
    Article
    18

    The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies.

    Published in:
    Expert Opinion on Therapeutic Targets, 2022, v. 26, n. 12, p. 1057, doi. 10.1080/14728222.2022.2170781
    By:
    • Sadeghi, Mohammad;
    • Khodakarami, Atefeh;
    • Ahmadi, Armin;
    • Fathi, Mehrdad;
    • Gholizadeh Navashenaq, Jamshid;
    • Mohammadi, Hamed;
    • Yousefi, Mehdi;
    • Hojjat-Farsangi, Mohammad;
    • Movasaghpour Akbari, Ali Akbar;
    • Jadidi-Niaragh, Farhad
    Publication type:
    Article
    19
    20

    Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.

    Published in:
    Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01213-1
    By:
    • Khodakarami, Atefeh;
    • Kashani, Mahsa Afsari;
    • Nazer, Atefeh;
    • Kheshti, Armin Mahmoudsalehi;
    • Rashidi, Bentolhoda;
    • Karpisheh, Vahid;
    • Masjedi, Ali;
    • Abolhasani, Shiva;
    • Izadi, Sepideh;
    • Bagherifar, Rafieh;
    • Hejazian, Seyyed Sina;
    • Mohammadi, Hamed;
    • Movassaghpour, AliAkbar;
    • Feizi, Abbas Ali Hosseinpour;
    • Hojjat-Farsangi, Mohammad;
    • Jadidi-Niaragh, Farhad
    Publication type:
    Article
    21

    The prognostic and therapeutic potential of HO-1 in leukemia and MDS.

    Published in:
    Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01074-8
    By:
    • Sadeghi, Mohammad;
    • Fathi, Mehrdad;
    • Gholizadeh Navashenaq, Jamshid;
    • Mohammadi, Hamed;
    • Yousefi, Mehdi;
    • Hojjat-Farsangi, Mohammad;
    • Namdar, Afshin;
    • Movasaghpour Akbari, Ali Akbar;
    • Jadidi-Niaragh, Farhad
    Publication type:
    Article
    22
    23
    24
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    The molecular biology and therapeutic potential of Nrf2 in leukemia.

    Published in:
    Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02660-5
    By:
    • Khodakarami, Atefeh;
    • Adibfar, Sara;
    • Karpisheh, Vahid;
    • Abolhasani, Shiva;
    • Jalali, Pooya;
    • Mohammadi, Hamed;
    • Gholizadeh Navashenaq, Jamshid;
    • Hojjat-Farsangi, Mohammad;
    • Jadidi-Niaragh, Farhad
    Publication type:
    Article
    45
    46
    47
    48
    49
    50